Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5198847
Max Phase: Preclinical
Molecular Formula: C19H18BrF2N3O2S
Molecular Weight: 470.34
Associated Items:
ID: ALA5198847
Max Phase: Preclinical
Molecular Formula: C19H18BrF2N3O2S
Molecular Weight: 470.34
Associated Items:
Canonical SMILES: O=S(=O)(c1ccccc1Br)n1cc(C(F)F)c2c(N3CCNCC3)cccc21
Standard InChI: InChI=1S/C19H18BrF2N3O2S/c20-14-4-1-2-7-17(14)28(26,27)25-12-13(19(21)22)18-15(5-3-6-16(18)25)24-10-8-23-9-11-24/h1-7,12,19,23H,8-11H2
Standard InChI Key: UHHZUOXKOCAANR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 470.34 | Molecular Weight (Monoisotopic): 469.0271 | AlogP: 3.99 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.34 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.84 | CX LogP: 3.73 | CX LogD: 2.29 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.63 | Np Likeness Score: -1.28 |
1. Yi C, Chen K, Liang H, Wang Z, Wang T, Li K, Yu J, Sun J, Jin C.. (2022) Novel difluoromethylated 1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole derivatives as potent 5-HT6 receptor antagonist with AMDE-improving properties: Design, synthesis, and biological evaluation., 71 [PMID:35926324] [10.1016/j.bmc.2022.116950] |
Source(1):